Evidence map›Paper›PMID 28693365›Full record

ArticleStem cells and development2017

Behavior of Xeno-Transplanted Undifferentiated Human Induced Pluripotent Stem Cells Is Impacted by Microenvironment Without Evidence of Tumors.

Veronica Martínez-Cerdeño, Bonnie L Barrilleaux, Ashley McDonough, Jeanelle Ariza, Benjamin T K Yuen, Priyanka Somanath, Catherine T Le, Craig Steward, Kayla Horton-Sparks, Paul S Knoepfler

Abstract read
In one paragraph

Article in Stem cells and development, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Veronica Martínez-Cerdeño1 Department of Pathology and Laboratory Medicine, University of California Davis School of Medicine , Sacramento, California.
Bonnie L Barrilleaux2 Institute for Regenerative Cures, University of California Davis School of Medicine , Sacramento, California.
Ashley McDonough3 Institute of Pediatric Regenerative Medicine , Shriners Hospital for Children, Northern California, Sacramento, California.
Jeanelle Ariza3 Institute of Pediatric Regenerative Medicine , Shriners Hospital for Children, Northern California, Sacramento, California.
Benjamin T K Yuen2 Institute for Regenerative Cures, University of California Davis School of Medicine , Sacramento, California.
Priyanka Somanath2 Institute for Regenerative Cures, University of California Davis School of Medicine , Sacramento, California.
Catherine T Le2 Institute for Regenerative Cures, University of California Davis School of Medicine , Sacramento, California.
Craig Steward3 Institute of Pediatric Regenerative Medicine , Shriners Hospital for Children, Northern California, Sacramento, California.
Kayla Horton-Sparks3 Institute of Pediatric Regenerative Medicine , Shriners Hospital for Children, Northern California, Sacramento, California.
Paul S Knoepfler2 Institute for Regenerative Cures, University of California Davis School of Medicine , Sacramento, California.

Funding

Myc Regulation of Embryonic Stem Cell Self-Renewal and PluripotencyR01GM100782 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KNOEPFLER, PAUL S · 2011 to 2015
$1.4M
Targeting a Novel H3.3 Epigenetic Switch to Regulate Health and DiseaseR01GM116919 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KNOEPFLER, PAUL S · 2016 to 2019
$1.4M
Howard Hughes Medical Institute 56006769NIGMS NIH HHS R01 GM100782NIGMS NIH HHS R01 GM116919
6 · The paper itself

Abstract

Human pluripotent stem cells (hPSC) have great clinical potential through the use of their differentiated progeny, a population in which there is some concern over risks of tumorigenicity or other unwanted cellular behavior due to residual hPSC. Preclinical studies using human stem cells are most often performed within a xenotransplant context. In this study, we sought to measure how undifferentiated hPSC behave following xenotransplant. We directly transplanted undifferentiated human induced pluripotent stem cells (hIPSC) and human embryonic stem cells (hESC) into the adult mouse brain ventricle and analyzed their fates. No tumors or precancerous lesions were present at more than one year after transplantation. This result differed with the tumorigenic capacity we observed after allotransplantation of mouse ESC into the mouse brain. A substantial population of cellular derivatives of undifferentiated hESC and hIPSC engrafted, survived, and migrated within the mouse brain parenchyma. Within brain structures, transplanted cell distribution followed a very specific pattern, suggesting the existence of distinct microenvironments that offer different degrees of permissibility for engraftment. Most of the transplanted hESC and hIPSC that developed into brain cells were NeuN+ neuronal cells, and no astrocytes were detected. Substantial cell and nuclear fusion occurred between host and transplanted cells, a phenomenon influenced by microenvironment. Overall, hIPSC appear to be largely functionally equivalent to hESC in vivo. Altogether, these data bring new insights into the behavior of stem cells without prior differentiation following xenotransplantation into the adult brain.

Indexed as

Stem Cell NicheAnimalsAstrocytesBrainCell LineCells, CulturedEmbryonic Stem CellsHumansInduced Pluripotent Stem CellsMiceMice, Inbred C57BLNeuronsStem Cell TransplantationTransplantation, Heterologouscell fatemicroenvironmentteratomatumorigenesis

Identifiers

PMID28693365
PMCPMC5647528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.